{
  "pmcid": "11508477",
  "sha256": "b812247c955fa41796cc46ec23415b20342204564edd6fec96c04f09db89c4bd",
  "timestamp_utc": "2025-11-09T23:16:51.319912+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.543436974789916,
    "reading_ease": 19.158180672268912,
    "word_count": 238
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Efficacy of Cell Salvage in Cardiac Surgery: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included adult participants undergoing cardiac surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "evaluate the efficacy of Cell Salvage compared to allogeneic transfusions"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to evaluate the efficacy of Cell Salvage compared to allogeneic transfusions."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the effectiveness of Cell Salvage on hemoglobin levels, measured postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation and allocation concealment methods varied across studies"
      },
      "Blinding": {
        "score": 0,
        "evidence": "blinding was not consistently reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Twenty-six studies with 2850 participants (1415 in the Cell Salvage group and 1435 in the control group) were included."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis was conducted using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Cell Salvage showed moderate evidence of greater effectiveness for hemoglobin (mean difference = 0.48 g/dL, 95% CI 0.28 to 0.69) compared to allogeneic transfusions."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: CRD42023446583."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}